Literature DB >> 1586189

Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator.

B Van Overmeire1, P J Van Reempts, K J Van Acker.   

Abstract

A newborn is described in whom the use of a central venous line was complicated by septicaemia and by intracardiac thrombus formation with tricuspid valve insufficiency and heart failure. Besides antibiotics, treatment consisted of tissue type plasminogen activator (tPA) for three days. This treatment resulted in the disappearance of the thrombus and the tricuspid insufficiency. No adverse effects were noted. Treatment with tPA should be considered in intracardiac thrombus formation with rapidly progressive heart failure in the neonate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586189      PMCID: PMC1590513          DOI: 10.1136/adc.67.4_spec_no.443

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator.

Authors:  L A Kennedy; W H Drummond; M E Knight; M M Millsaps; J L Williams
Journal:  J Pediatr       Date:  1990-05       Impact factor: 4.406

2.  Fibrinolysis by tissue plasminogen activator in a child with pulmonary embolism.

Authors:  L A Pyles; M E Pierpont; M E Steiner; P S Hesslein; C M Smith
Journal:  J Pediatr       Date:  1990-05       Impact factor: 4.406

Review 3.  Coagulase-negative staphylococcal infection in the neonate.

Authors:  J W St Geme; M C Harris
Journal:  Clin Perinatol       Date:  1991-06       Impact factor: 3.430

Review 4.  Thrombolytic therapy: current status (1).

Authors:  V J Marder; S Sherry
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

5.  Urokinase therapy for a catheter-related right atrial thrombus.

Authors:  D Delaplane; J P Scott; T W Riggs; B L Silverman; C E Hunt
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

Review 6.  Tissue plasminogen activator: a new thrombolytic agent.

Authors:  S J Crabbe; C C Cloninger
Journal:  Clin Pharm       Date:  1987-05

Review 7.  Thrombotic disease in newborn infants.

Authors:  B Schmidt; A Zipursky
Journal:  Clin Perinatol       Date:  1984-06       Impact factor: 3.430

8.  Tissue plasminogen activator for the treatment of thromboembolism in infants and children.

Authors:  M Levy; L N Benson; P E Burrows; Y Bentur; D K Strong; J Smith; D Johnson; S Jacobson; G Koren
Journal:  J Pediatr       Date:  1991-03       Impact factor: 4.406

9.  Changing spectrum of infective endocarditis in children. Analysis of 26 cases, 1970-1979.

Authors:  B F Stanton; R S Baltimore; J D Clemens
Journal:  Am J Dis Child       Date:  1984-08

10.  Neonatal Staphylococcus epidermidis right-sided endocarditis: description of five catheterized infants.

Authors:  G J Noel; J E O'Loughlin; P J Edelson
Journal:  Pediatrics       Date:  1988-08       Impact factor: 7.124

View more
  7 in total

Review 1.  Case study and review: treatment of tricuspid prosthetic valve thrombosis.

Authors:  David Yi Zhang; Jay Lozier; Richard Chang; Vandana Sachdev; Marcus Y Chen; Jennifer L Audibert; Keith A Horvath; Douglas R Rosing
Journal:  Int J Cardiol       Date:  2011-10-14       Impact factor: 4.164

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Left atrial thrombus in a 10-month-old boy--successful thrombolysis with recombinant tissue-type plasminogen activator after open-heart surgery: review of the literature.

Authors:  H G Kehl; D Kececioglu; H Vielhaber; S Kotthoff; M Weyand; G Jorch; J Vogt; U Nowak-Göttl
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 4.  Management of preterm infants with intracardiac thrombi: use of thrombolytic agents.

Authors:  P C Rimensberger; J R Humbert; M Beghetti
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Outcome of cardiac thrombi in infants.

Authors:  Edgard A Bendaly; Anjan S Batra; Eric S Ebenroth; Roger A Hurwitz
Journal:  Pediatr Cardiol       Date:  2007-09-01       Impact factor: 1.655

Review 6.  Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.

Authors:  A J Wagstaff; J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

7.  Management and outcome in 32 neonates with thrombotic events.

Authors:  H A van Elteren; H S Veldt; A B Te Pas; A A W Roest; F J Smiers; W J Kollen; A Sramek; F J Walther; E Lopriore
Journal:  Int J Pediatr       Date:  2011-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.